S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

RedHill Biopharma (RDHL) Competitors

$0.40
-0.02 (-4.72%)
(As of 04/15/2024 ET)

RDHL vs. COCP, TNXP, BNTC, NNVC, ORGS, MIRA, KPRX, TRAW, AVTX, and JAN

Should you be buying RedHill Biopharma stock or one of its competitors? The main competitors of RedHill Biopharma include Cocrystal Pharma (COCP), Tonix Pharmaceuticals (TNXP), Benitec Biopharma (BNTC), NanoViricides (NNVC), Orgenesis (ORGS), MIRA Pharmaceuticals (MIRA), Kiora Pharmaceuticals (KPRX), Traws Pharma (TRAW), Avalo Therapeutics (AVTX), and JanOne (JAN). These companies are all part of the "pharmaceutical preparations" industry.

RedHill Biopharma vs.

Cocrystal Pharma (NASDAQ:COCP) and RedHill Biopharma (NASDAQ:RDHL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, community ranking, institutional ownership and dividends.

6.7% of Cocrystal Pharma shares are owned by institutional investors. Comparatively, 7.2% of RedHill Biopharma shares are owned by institutional investors. 25.1% of Cocrystal Pharma shares are owned by insiders. Comparatively, 6.8% of RedHill Biopharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cocrystal Pharma's return on equity of 0.00% beat RedHill Biopharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Cocrystal PharmaN/A -59.62% -54.62%
RedHill Biopharma N/A N/A N/A

RedHill Biopharma received 406 more outperform votes than Cocrystal Pharma when rated by MarketBeat users. However, 75.00% of users gave Cocrystal Pharma an outperform vote while only 69.43% of users gave RedHill Biopharma an outperform vote.

CompanyUnderperformOutperform
Cocrystal PharmaOutperform Votes
21
75.00%
Underperform Votes
7
25.00%
RedHill BiopharmaOutperform Votes
427
69.43%
Underperform Votes
188
30.57%

Cocrystal Pharma has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, RedHill Biopharma has a beta of 3.45, indicating that its share price is 245% more volatile than the S&P 500.

In the previous week, Cocrystal Pharma and Cocrystal Pharma both had 3 articles in the media. RedHill Biopharma's average media sentiment score of 0.71 beat Cocrystal Pharma's score of 0.39 indicating that Cocrystal Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Cocrystal Pharma Positive
RedHill Biopharma Neutral

RedHill Biopharma has higher revenue and earnings than Cocrystal Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cocrystal PharmaN/AN/A-$17.98M-$1.99-0.70
RedHill Biopharma$6.53M1.84$23.92MN/AN/A

Cocrystal Pharma presently has a consensus target price of $10.00, suggesting a potential upside of 614.29%. Given RedHill Biopharma's higher possible upside, equities research analysts clearly believe Cocrystal Pharma is more favorable than RedHill Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cocrystal Pharma
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
RedHill Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

RedHill Biopharma beats Cocrystal Pharma on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RDHL vs. The Competition

MetricRedHill BiopharmaPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$12.64M$6.35B$4.74B$7.56B
Dividend YieldN/A3.07%5.44%3.96%
P/E RatioN/A7.96192.1815.42
Price / Sales1.84332.222,413.7391.56
Price / Cash0.3220.1333.1228.20
Price / Book3.675.564.674.26
Net Income$23.92M$130.38M$99.83M$211.03M
7 Day Performance-18.61%-5.18%-4.37%-4.55%
1 Month Performance-23.29%-4.57%-3.19%-2.06%
1 Year Performance-87.41%2.57%12.64%6.74%

RedHill Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COCP
Cocrystal Pharma
2.7659 of 5 stars
$1.54
-1.3%
$10.00
+549.4%
-41.2%$15.66MN/A-0.7712
TNXP
Tonix Pharmaceuticals
2.8502 of 5 stars
$0.19
flat
$5.50
+2,857.0%
-95.5%$15.67M$7.77M-0.02117Short Interest ↑
Gap Up
BNTC
Benitec Biopharma
1.5757 of 5 stars
$5.90
+4.2%
$10.00
+69.5%
+35.3%$15.29M$80,000.00-2.3118
NNVC
NanoViricides
0 of 5 stars
$1.35
-2.9%
N/A-1.7%$15.90MN/A-1.677Analyst Report
News Coverage
ORGS
Orgenesis
2.1813 of 5 stars
$0.48
flat
N/A-56.5%$15.21M$36.03M-0.52167News Coverage
MIRA
MIRA Pharmaceuticals
0.7097 of 5 stars
$1.02
-1.0%
N/AN/A$15.08MN/A0.002
KPRX
Kiora Pharmaceuticals
3.0428 of 5 stars
$0.57
-3.4%
$7.00
+1,128.7%
-86.5%$14.96MN/A0.0012Positive News
TRAW
Traws Pharma
0 of 5 stars
$0.77
-1.3%
N/AN/A$16.21M$230,000.00-0.85N/APositive News
Gap Up
AVTX
Avalo Therapeutics
0 of 5 stars
$14.48
+2.0%
N/A-97.6%$14.91M$1.92M-0.0220Short Interest ↑
JAN
JanOne
0 of 5 stars
$2.98
+18.3%
N/A+227.7%$14.78M$39.61M0.00199Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:RDHL) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners